Starting January 1, 2026, New Yorkers will benefit from new health care laws designed to enhance insurance coverage and reduce out-of-pocket costs for essential medical services. The legislation mandates that insurers must cover medically necessary EpiPens, expand breast cancer screening and imaging options, and provide coverage for scalp cooling systems utilized during chemotherapy. Governor Kathy Hochul stated, “New Yorkers shouldn’t have to choose between putting food on the table or being able to afford life-saving medical devices and procedures.”
Enhanced Coverage for EpiPens
EpiPens, critical for treating severe allergic reactions, have been a financial burden for many patients. Over the past decade, prices have surged dramatically, with a pack of two pens now costing around $600, a significant increase from approximately $60 when Mylan acquired the product in 2007. Given the short shelf life of these devices, roughly 12 months, many individuals find themselves needing to replace them annually. The new law stipulates that insurers in both individual and group markets, including non-profit providers and Health Maintenance Organizations (HMOs), must cover medically necessary EpiPens for emergency allergic reactions. Furthermore, patients will face a cap on out-of-pocket expenses at $100 per year.
Expanded Breast Cancer Screening Initiatives
Breast cancer remains a significant health challenge in New York, with more than 17,000 diagnoses and nearly 2,400 deaths reported annually. The updated legislation addresses this issue by ensuring that individual, group, and non-profit health plans cover breast cancer screening and diagnostic imaging, such as mammograms, ultrasounds, and MRIs, when recommended by a physician according to established clinical guidelines. Cost-sharing will not apply, except in cases affecting eligibility for health savings accounts.
Coverage for Scalp Cooling Systems
In a notable first for the United States, the new law will also require coverage for scalp cooling systems designed to minimize hair loss during chemotherapy. Without insurance, the cost of utilizing scalp cooling during chemotherapy can range from $1,500 to $3,000. The U.S. Food and Drug Administration has approved three different scalp cooling systems, which function by reducing the amount of chemotherapy that reaches hair follicles, allowing patients to maintain their hair and a sense of normalcy during treatment. Advocates and lawmakers emphasize that this coverage helps preserve dignity and alleviate stress for patients undergoing chemotherapy, addressing the emotional aspects of cancer care beyond mere medical treatment.
These legislative changes reflect a growing recognition that comprehensive health care must encompass both physical and emotional well-being for patients. As New York implements these new protections, individuals facing significant health challenges will find greater support and resources to manage their conditions effectively.
